About Jüdisches Krankenhaus Berlin
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
ResMed
3
Charite University, Berlin, Germany
2
Genzyme, a Sanofi Company
2
Abbott Medical Devices
1
Biogen
1
Biotronik, Inc.
1
Boston Scientific Corporation
1
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III
1
Grifols Therapeutics LLC
1
Leipzig Heart Institute GmbH
1
Spectranetics Corporation
1
Clinical Trials at Jüdisches Krankenhaus Berlin
During the past decade, Jüdisches Krankenhaus Berlin conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 6 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
2002-01-01
2005-12-01
Completed
1,200
Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
2004-04-01
2006-06-01
Completed
117
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
2007-08-01
2011-04-01
Completed
581
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
2007-10-01
2011-09-01
Completed
840
Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)
2008-08-01
2013-03-01
Terminated
1,680
Treatment of Predominant Central Sleep Apnoea by Adaptive Servo Ventilation in Patients With Heart Failure
2008-02-01
2015-06-01
Completed
1,325
A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
2009-11-01
2011-12-01
Terminated
173
Substudy on the Mechanistic Plausibility of the Clinical Benefits of Adaptive Servo-ventilation
2012-08-01
2015-06-01
Completed
312
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Jüdisches Krankenhaus Berlin" #1 sponsor was "ResMed" with 3 trials, followed by "Charite University, Berlin, Germany" with 2 trials
sponsored, "Genzyme, a Sanofi Company" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored and "Biogen"
with 1 trials sponsored. Other sponsors include 2 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Jüdisches Krankenhaus Berlin"
#1 collaborator was "Bayer" with 2 trials as a collaborator, "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator, "Centre Hospitalier Universitaire de Besancon" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator and "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were
collaborators in the rest 18 trials.
Clinical Trials Conditions at Jüdisches Krankenhaus Berlin
According to Clinical.Site data, the most researched conditions in "Jüdisches Krankenhaus Berlin" are
"Heart Failure" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "Chronic Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Blood Pressure" (1 trials). Many other conditions were trialed in "Jüdisches Krankenhaus Berlin" in a lesser frequency.
Clinical Trials Intervention Types at Jüdisches Krankenhaus Berlin
Most popular intervention types in "Jüdisches Krankenhaus Berlin" are "Device" (6 trials), "Drug" (4 trials), "Biological" (2 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Interferon beta-1a" (2 trials), "Placebo" (2 trials), "Albumin (Human) 25%, United States Pharmacopeia (USP)" (1 trials), "Alemtuzumab" (1 trials) and "Alemtuzumab 12 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Jüdisches Krankenhaus Berlin
The vast majority of trials in "Jüdisches Krankenhaus Berlin" are
16 trials for "All" genders.
Clinical Trials Status at Jüdisches Krankenhaus Berlin
Currently, there are NaN active trials in "Jüdisches Krankenhaus Berlin".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in Jüdisches Krankenhaus Berlin,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Jüdisches Krankenhaus Berlin, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 3 trials that are defined as “Not Applicable".
Departments of Jüdisches Krankenhaus Berlin
Jüdisches Krankenhaus Berlin has several departments that took part in Clinical trials: "Jüdisches Krankenhaus Berlin; Abteilung fur Neurologie" - 5 trials
Departments List
Name
City
Trials